Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.

Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):600-6. Epub 2007 Jan 4.

PMID:
17204667
[PubMed - indexed for MEDLINE]
Free Article
2.

Secretory phospholipase A2 enzymes in atherogenesis.

Webb NR.

Curr Opin Lipidol. 2005 Jun;16(3):341-4. Review.

PMID:
15891396
[PubMed - indexed for MEDLINE]
3.

New phospholipase A(2) isozymes with a potential role in atherosclerosis.

Murakami M, Kudo I.

Curr Opin Lipidol. 2003 Oct;14(5):431-6. Review.

PMID:
14501581
[PubMed - indexed for MEDLINE]
4.

Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?

Menschikowski M, Hagelgans A, Siegert G.

Prostaglandins Other Lipid Mediat. 2006 Mar;79(1-2):1-33. Epub 2005 Dec 27. Review.

PMID:
16516807
[PubMed - indexed for MEDLINE]
5.

Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis.

Jaross W, Eckey R, Menschikowski M.

Eur J Clin Invest. 2002 Jun;32(6):383-93. Review.

PMID:
12059982
[PubMed - indexed for MEDLINE]
6.

[Functional analysis of phospholipase A2 receptor by gene knockout studies].

Yokota Y.

Yakugaku Zasshi. 2001 Jan;121(1):23-33. Review. Japanese.

PMID:
11201160
[PubMed - indexed for MEDLINE]
Free Article
7.

Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis.

Rosengren B, Jönsson-Rylander AC, Peilot H, Camejo G, Hurt-Camejo E.

Biochim Biophys Acta. 2006 Nov;1761(11):1301-8. Epub 2006 Jul 8. Review.

PMID:
17070102
[PubMed - indexed for MEDLINE]
Free Article
8.

Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?

Niessen HW, Krijnen PA, Visser CA, Meijer CJ, Erik Hack C.

Cardiovasc Res. 2003 Oct 15;60(1):68-77. Review.

PMID:
14522408
[PubMed - indexed for MEDLINE]
Free Article
9.

Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis.

Oörni K, Kovanen PT.

Curr Opin Lipidol. 2009 Oct;20(5):421-7. doi: 10.1097/MOL.0b013e32832fa14d. Review.

PMID:
19593123
[PubMed - indexed for MEDLINE]
10.

Phospholipase A2 and small, dense low-density lipoprotein.

Hurt-Camejo E, Camejo G, Sartipy P.

Curr Opin Lipidol. 2000 Oct;11(5):465-71. Review.

PMID:
11048889
[PubMed - indexed for MEDLINE]
11.

[Role of type II secreted phospholipase A2 in inflammatory processes].

Jacques C, Berenbaum F.

C R Seances Soc Biol Fil. 1996;190(4):437-43. Review. French.

PMID:
8952894
[PubMed - indexed for MEDLINE]
12.

The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.

Tellis CC, Tselepis AD.

Biochim Biophys Acta. 2009 May;1791(5):327-38. doi: 10.1016/j.bbalip.2009.02.015. Review.

PMID:
19272461
[PubMed - indexed for MEDLINE]
Free Article
13.

Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis.

Zalewski A, Macphee C, Nelson JJ.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):527-32. Review.

PMID:
16503872
[PubMed - indexed for MEDLINE]
14.

PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis.

Oestvang J, Johansen B.

Biochim Biophys Acta. 2006 Nov;1761(11):1309-16. Epub 2006 Jul 1. Review.

PMID:
16904370
[PubMed - indexed for MEDLINE]
Free Article
15.

Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2.

Hanasaki K, Arita H.

Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:71-82. Review.

PMID:
12432910
[PubMed - indexed for MEDLINE]
16.

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

Zalewski A, Macphee C.

Arterioscler Thromb Vasc Biol. 2005 May;25(5):923-31. Epub 2005 Feb 24. Review.

PMID:
15731492
[PubMed - indexed for MEDLINE]
Free Article
17.

Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors.

Lucas KK, Dennis EA.

Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):235-48. Review.

PMID:
16099408
[PubMed - indexed for MEDLINE]
18.

Role of secretory phospholipases in atherogenesis.

Jönsson-Rylander AC, Lundin S, Rosengren B, Pettersson C, Hurt-Camejo E.

Curr Atheroscler Rep. 2008 Jun;10(3):252-9. Review.

PMID:
18489854
[PubMed - indexed for MEDLINE]
19.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
[PubMed - indexed for MEDLINE]
20.

MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2.

Gorovetz M, Schwob O, Krimsky M, Yedgar S, Reich R.

Front Biosci. 2008 Jan 1;13:1917-25. Review.

PMID:
17981679
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk